These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2786663

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Induction of anticentromere antibody in patients receiving treatment with D-penicillamine.
    Haberhauer G.
    Klin Wochenschr; 1989 May 15; 67(10):535-7. PubMed ID: 2786978
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anticentromere antibody and primary pulmonary hypertension.
    Seibold JR, Trontell MC.
    J Rheumatol; 1982 May 15; 9(4):607-9. PubMed ID: 6752406
    [Abstract] [Full Text] [Related]

  • 5. D-penicillamine (DPA)-induced anticentromere antibody (ACA).
    Haberhauer G.
    Clin Exp Rheumatol; 1989 May 15; 7(3):332-4. PubMed ID: 2758714
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y, Shibata M, Yonezawa H, Terauti K, Miyachi K, Ueno Y.
    Rinsho Byori; 1996 Sep 15; 44(9):877-82. PubMed ID: 8911074
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
    Kremer L, Alvaro-Gracia JM, Ossorio C, Avila J.
    Clin Exp Immunol; 1988 Jun 15; 72(3):465-9. PubMed ID: 3048807
    [Abstract] [Full Text] [Related]

  • 11. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD, Smith CD, Senecal JL, Rothfield N.
    Arthritis Rheum; 1984 Feb 15; 27(2):121-4. PubMed ID: 6607733
    [Abstract] [Full Text] [Related]

  • 12. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY, Fedrick JA, Pandey JP, Silver R, Maricq HR, Fudenberg HH, Dobson RL, Ainsworth SK.
    Arch Dermatol; 1985 Mar 15; 121(3):339-44. PubMed ID: 3883903
    [Abstract] [Full Text] [Related]

  • 13. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O, Haim T, Ryckewaert A.
    Rev Rhum Mal Osteoartic; 1983 Apr 15; 50(4):261-6. PubMed ID: 6348931
    [Abstract] [Full Text] [Related]

  • 14. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K, Kondo H, Kashiwazaki S.
    Ryumachi; 1984 Aug 15; 24(4):241-9. PubMed ID: 6334895
    [No Abstract] [Full Text] [Related]

  • 15. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
    Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X.
    J Rheumatol; 2007 Nov 15; 34(11):2253-8. PubMed ID: 17937465
    [Abstract] [Full Text] [Related]

  • 16. Anticentromere antibodies--clinical correlates.
    Wade JP, Sack B, Schur PH.
    J Rheumatol; 1988 Dec 15; 15(12):1759-63. PubMed ID: 3265957
    [Abstract] [Full Text] [Related]

  • 17. [Changes in various humoral immunity indicators during the treatment of rheumatoid arthritis with D-penicillamine (cuprenil)].
    Chwalińska-Sadowska H, Małdykowa H, Zajaczek-Grabowska A, Dratwianka B, Abgarowicz-Miłkowska T, Swierczyńska Z, Orłowska G, Rdułtowska H, Luft S, Rogozińska E.
    Reumatologia; 1981 Dec 15; 19(2):151-7. PubMed ID: 6459630
    [No Abstract] [Full Text] [Related]

  • 18. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS.
    Arthritis Rheum; 1998 Nov 15; 41(11):1938-45. PubMed ID: 9811047
    [Abstract] [Full Text] [Related]

  • 19. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D, Grodzicky T, Senécal JL.
    Clin Immunol; 1999 Feb 15; 90(2):182-9. PubMed ID: 10080829
    [Abstract] [Full Text] [Related]

  • 20. A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis.
    McNeilage LJ, Whittingham S, McHugh N, Barnett AJ.
    J Immunol; 1986 Oct 15; 137(8):2541-7. PubMed ID: 3531335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.